Anti-Inflammatory Treatments for Major Depressive Disorder: What's on the Horizon?

被引:4
|
作者
Kumar, Manish [1 ,2 ,3 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Psychiat, 1 Gustave L Levy Pl,Box 1230, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Neurosci, 1 Gustave L Levy Pl,Box 1230, New York, NY 10029 USA
[3] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA
关键词
STAR-ASTERISK-D; DOUBLE-BLIND; SYMPTOMS; ASSOCIATION; BIOMARKER; OUTCOMES; MINOCYCLINE; ANHEDONIA;
D O I
10.4088/JCP.18ac12630
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [1] Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder
    Uher, R.
    Carver, S.
    Power, R. A.
    Mors, O.
    Maier, W.
    Rietschel, M.
    Hauser, J.
    Dernovsek, M. Z.
    Henigsberg, N.
    Souery, D.
    Placentino, A.
    Farmer, A.
    McGuffin, P.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (10) : 2027 - 2035
  • [2] Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder
    Wessa, Celine
    Morrens, Manuel
    De Picker, Livia J.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 515 - 517
  • [3] Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
    Su, Wen-Jun
    Hu, Ting
    Jiang, Chun-Lei
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (05) : 810 - 842
  • [4] Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials
    Kohler-Forsherg, O.
    Lydholm, C. N.
    Hjorthoj, C.
    Nordentoft, M.
    Mors, O.
    Benros, M. E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (05) : 404 - 419
  • [5] Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
    Simon, Maria S.
    Arteaga-Henriquez, Gara
    Algendy, Ahmed Fouad
    Siepmann, Timo
    Illigens, Ben M. W.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 1 - 25
  • [6] Vitamin E for the management of major depressive disorder: possible role of the anti-inflammatory and antioxidant systems
    Manosso, Luana M.
    Camargo, Anderson
    Dafre, Alcir L.
    Rodrigues, Ana Lucia S.
    NUTRITIONAL NEUROSCIENCE, 2022, 25 (06) : 1310 - 1324
  • [7] Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis
    Du, Yue
    Dou, Yikai
    Wang, Min
    Wang, Yu
    Yan, Yushun
    Fan, Huanhuan
    Fan, Ningdan
    Yang, Xiao
    Ma, Xiaohong
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [8] Comparative Efficacy and Acceptability of Anti-inflammatory Agents on Major Depressive Disorder: A Network Meta-Analysis
    Hang, Xiaoyi
    Zhang, Yijie
    Li, Jingjing
    Li, Zhenzhen
    Zhang, Yi
    Ye, Xuanhao
    Tang, Qisheng
    Sun, Wenjun
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Efficacy of addition of the anti-inflammatory, IV glutathione to standard ketamine IV therapy in major depressive disorder
    Eshkevari, Ladan
    Sales, Michelle
    Collins, Christina
    Totoraitis, Julia
    Donohue, Lindsay
    Bowman-Dalley, Carrie
    Bregman, Bejamin
    Negro, Paulo
    Gordon, Stephanie
    Estrada, Christian
    PSYCHIATRY RESEARCH, 2024, 337
  • [10] Brain Responses to Emotional Stimuli after Eicosapentaenoic Acid and Docosahexaenoic Acid Treatments in Major Depressive Disorder: Toward Personalized Medicine with Anti-Inflammatory Nutraceuticals
    Tu, Cheng-Hao
    Chen, Chun-Ming
    Yang, Chuan-Chih
    Galecki, Piotr
    Su, Kuan-Pin
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 14